130 related articles for article (PubMed ID: 26029741)
1. Regulation of Aspartyl-(Asparaginyl)-β-Hydroxylase Protein Expression and Function by Phosphorylation in Hepatocellular Carcinoma Cells.
Borgas DL; Gao JS; Tong M; Roper N; de la Monte SM
J Nat Sci; 2015 Apr; 1(4):. PubMed ID: 26029741
[TBL] [Abstract][Full Text] [Related]
2. Potential Role of Phosphorylation as a Regulator of Aspartyl-(asparaginyl)-β-hydroxylase: Relevance to Infiltrative Spread of Human Hepatocellular Carcinoma.
Borgas DL; Gao JS; Tong M; de la Monte SM
Liver Cancer; 2015 Sep; 4(3):139-53. PubMed ID: 26675015
[TBL] [Abstract][Full Text] [Related]
3. Ethanol impaired neuronal migration is associated with reduced aspartyl-asparaginyl-beta-hydroxylase expression.
Carter JJ; Tong M; Silbermann E; Lahousse SA; Ding FF; Longato L; Roper N; Wands JR; de la Monte SM
Acta Neuropathol; 2008 Sep; 116(3):303-15. PubMed ID: 18478238
[TBL] [Abstract][Full Text] [Related]
4. Ethanol inhibition of aspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: potential link to the impairments in central nervous system neuronal migration.
de la Monte SM; Tong M; Carlson RI; Carter JJ; Longato L; Silbermann E; Wands JR
Alcohol; 2009 May; 43(3):225-40. PubMed ID: 19393862
[TBL] [Abstract][Full Text] [Related]
5. Role of aspartyl-(asparaginyl)-β-hydroxylase mediated notch signaling in cerebellar development and function.
Silbermann E; Moskal P; Bowling N; Tong M; de la Monte SM
Behav Brain Funct; 2010 Nov; 6():68. PubMed ID: 21050474
[TBL] [Abstract][Full Text] [Related]
6. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
de la Monte SM; Tamaki S; Cantarini MC; Ince N; Wiedmann M; Carter JJ; Lahousse SA; Califano S; Maeda T; Ueno T; D'Errico A; Trevisani F; Wands JR
J Hepatol; 2006 May; 44(5):971-83. PubMed ID: 16564107
[TBL] [Abstract][Full Text] [Related]
7. Aspartyl-(asparaginyl) beta-hydroxylase, hypoxia-inducible factor-alpha and Notch cross-talk in regulating neuronal motility.
Lawton M; Tong M; Gundogan F; Wands JR; de la Monte SM
Oxid Med Cell Longev; 2010; 3(5):347-56. PubMed ID: 21150341
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation Modulates Aspartyl-(Asparaginyl)-β Hydroxylase Protein Expression, Catalytic Activity and Migration in Human Immature Neuronal Cerebellar Cells.
Tong M; Gao JS; Borgas D; de la Monte SM
Cell Biol (Henderson, NV); 2013 Sep; 6(2):. PubMed ID: 29607347
[TBL] [Abstract][Full Text] [Related]
9. Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells.
Lahousse SA; Carter JJ; Xu XJ; Wands JR; de la Monte SM
BMC Cell Biol; 2006 Dec; 7():41. PubMed ID: 17156427
[TBL] [Abstract][Full Text] [Related]
10. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.
Cantarini MC; de la Monte SM; Pang M; Tong M; D'Errico A; Trevisani F; Wands JR
Hepatology; 2006 Aug; 44(2):446-57. PubMed ID: 16871543
[TBL] [Abstract][Full Text] [Related]
11. Ceramide inhibitor myriocin restores insulin/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis.
Lizarazo D; Zabala V; Tong M; Longato L; de la Monte SM
J Gastroenterol Hepatol; 2013 Oct; 28(10):1660-8. PubMed ID: 23802886
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) beta-hydroxylase suppress migration of cholangiocarcinoma cells.
Maeda T; Sepe P; Lahousse S; Tamaki S; Enjoji M; Wands JR; de la Monte SM
J Hepatol; 2003 May; 38(5):615-22. PubMed ID: 12713872
[TBL] [Abstract][Full Text] [Related]
13. siRNA inhibition of aspartyl-asparaginyl β-hydroxylase expression impairs cell motility, Notch signaling, and fetal growth.
Gundogan F; Bedoya A; Gilligan J; Lau E; Mark P; De Paepe ME; de la Monte SM
Pathol Res Pract; 2011 Sep; 207(9):545-53. PubMed ID: 21862239
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.
Maeda T; Taguchi K; Aishima S; Shimada M; Hintz D; Larusso N; Gores G; Tsuneyoshi M; Sugimachi K; Wands JR; de la Monte SM
Cancer Detect Prev; 2004; 28(5):313-8. PubMed ID: 15542253
[TBL] [Abstract][Full Text] [Related]
16. Proteomic identification of 14-3-3zeta as an adapter for IGF-1 and Akt/GSK-3beta signaling and survival of renal mesangial cells.
Singh LP; Jiang Y; Cheng DW
Int J Biol Sci; 2006 Oct; 3(1):27-39. PubMed ID: 17200689
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome.
Wang K; Liu J; Yan ZL; Li J; Shi LH; Cong WM; Xia Y; Zou QF; Xi T; Shen F; Wang HY; Wu MC
Hepatology; 2010 Jul; 52(1):164-73. PubMed ID: 20578260
[TBL] [Abstract][Full Text] [Related]
18. Role of the aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motility.
Sepe PS; Lahousse SA; Gemelli B; Chang H; Maeda T; Wands JR; de la Monte SM
Lab Invest; 2002 Jul; 82(7):881-91. PubMed ID: 12118090
[TBL] [Abstract][Full Text] [Related]
19. The aspartyl (asparaginyl) beta-hydroxylase in carcinomas.
Yang H; Li J; Tang R; Li J; Liu Y; Ye L; Shao D; Jin M; Huang Q; Shi J
Front Biosci (Landmark Ed); 2015 Jan; 20(5):902-9. PubMed ID: 25553486
[TBL] [Abstract][Full Text] [Related]
20. Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3 beta activity.
Kuemmerle JF
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G101-10. PubMed ID: 15297258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
